Adicet is a biotechnology company engaged in the development of first-in-class off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases.| www.adicetbio.com
Adicet is actively developing promising best-in-class therapies to treat hematological malignancies and solid tumors. The company is expanding its pipeline.| www.adicetbio.com